ArticleGastro hep advances2025

Effect of Risankizumab Induction and Maintenance Therapy on the Rate of Hospitalization in Patients with Crohn's Disease.

Brian G Feagan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.